State KS
Clinical Trials in Kansas
Recruiting clinical trials with at least one study location in Kansas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kansas
NCT06060548 N/A
Recruiting
Role of Novel ILR in the Management of PVCs
Condition
PVC - Premature Ventricular Contraction
Enrollment
50 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
NCT06481306 Phase 1, Phase 2
Recruiting
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickl...
Condition
Anemia, Sickle Cell
Enrollment
184 pts
Location
United States, France, United Kingdom
Sponsor
Bristol-Myers Squibb
NCT07242118 N/A
Recruiting
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Under...
Condition
Breast Cancer Female
Enrollment
18 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07021885 N/A
Recruiting
NLit and Outcomes in HNC Survivor-Caregiver Dyads
Condition
Head and Neck Cancer
Enrollment
150 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07422987 N/A
Recruiting
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Condition
Body Composition
Enrollment
50 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu...
Condition
Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canada, France
Sponsor
Marengo Therapeutics, Inc.
NCT07207408 Phase 2
Recruiting
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55...
Condition
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Enrollment
148 pts
Location
United States
Sponsor
Dynavax Technologies Corporati
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disord...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT06773962 Phase 2
Recruiting
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's ...
Condition
Parkinson's Disease (PD)
Enrollment
62 pts
Location
United States
Sponsor
TrueBinding, Inc.
NCT06782490 Phase 2
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Parti...
Condition
Multiple Sclerosis Spasticity
Enrollment
200 pts
Location
United States, Australia, Canada
Sponsor
Celgene
NCT07199569 Phase 2
Recruiting
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production C...
Condition
Monkeypox (Mpox)
Enrollment
744 pts
Location
United States
Sponsor
Bavarian Nordic
NCT06858397 Phase 1, Phase 2
Recruiting
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in...
Condition
Fabry Disesase
Enrollment
18 pts
Location
United States, Argentina, South Korea
Sponsor
GC Biopharma Corp
NCT06576661 N/A
Recruiting
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitori...
Condition
Kidney Stone
Enrollment
80 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06297291 N/A
Recruiting
Global Paradise System US Post Approval Study
Condition
Hypertension
Enrollment
1,000 pts
Location
United States
Sponsor
ReCor Medical, Inc.
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Condition
Colorectal Cancer
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT05999240 Phase 2
Recruiting
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Condition
Autism Spectrum Disorder
Enrollment
30 pts
Location
United States
Sponsor
New York State Psychiatric Ins
NCT06281678 Phase 2
Recruiting
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Condition
Melanoma
Enrollment
178 pts
Location
United States
Sponsor
Innovent Biologics (Suzhou) Co
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04808596 N/A
Recruiting
Pulmonary Hypertension Biorepository and Registry
Condition
Pulmonary Hypertension
Enrollment
300 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06603597 N/A
Recruiting
HER2-positive Breast Cancer Registry
Condition
HER2 + Breast Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Priyanka Sharma
NCT06902558 Phase 2
Recruiting
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of A...
Condition
Autosomal Dominant Polycystic Kidney Disease
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT06667076 Phase 2
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combina...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
480 pts
Location
United States, Belgium, Finland
Sponsor
Janssen Research & Development